Orlando, FL -- (SBWIRE) -- 10/29/2013 -- Hot Stock Profits provides investors and traders with valuable trading tools and content as well as micro-cap stock alerts via eMail and text messages. To Join Our Text Message Alerts Service Just Text The Word Stocks To 555888 From Your Cell Phone. Our Focus Today Is On Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Amgen, Inc.(NASDAQ:AMGN).
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) stock closed at $4.75. The company on Oct. 15 reported that Eisai Inc. will increase its BELVIQ sales force to approximately 400 representatives by December 2013, doubling the size of the sales force from when BELVIQ became available in June 2013. The expansion of the sales force, which has commenced and follows increases in coverage of BELVIQ by health plans and pharmacy benefit managers (PBMs) since the launch, will enable Eisai to reach approximately 65,000 physicians in the United States, including primary care providers, endocrinologists, cardiovascular specialists and gastrointestinal specialists.
Are investors worried about the recent updates with ARNA? Find out with a free trend analysis HERE
Amgen, Inc.(NASDAQ:AMGN) shares jumped 1.73% to $118.33. The company on Oct. 22 reported third-quarter net income of $1.4 billion or $1.79 per share, compared to $1.1 billion or $1.41 per share in the comparable quarter last year. Adjusted net income for the quarter rose to $1.5 billion or $1.94 per share from $1.3 billion or $1.67 per share last year. Analysts expected earnings of $1.77 per share for the quarter. Total revenues for the quarter increased 10 percent to $4.75 billion from $4.32 billion in the year-ago period, while analysts estimated revenues of $4.60 billion for the quarter.
Is AMGN going to continue its rally or drop like a rock? Find out with a free trend analysis HERE
Join Our Mobile SMS Alerts By Texting Stocks To 555888
HotStockProfits.com continuously monitors and scans the markets for day trading and swing trading signals on NASDAQ, NYSE, AMEX, OTCBB and Pink Sheet companies for its free e-newsletter subscribers.
HotStockProfits.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit HotStockProfits.com website, for complete risks and disclosures.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)